Skip to content

Intrapartum Study of Sterile and Clean Gloves

A Comparison of Sterile and Non-sterile Gloves for the Incidence of Chorioamnionitis During Labor: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01852188
Enrollment
507
Registered
2013-05-13
Start date
2011-05-31
Completion date
2014-11-02
Last updated
2018-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chorioamnionitis

Keywords

Intrapartum, Glove, Chorioamnionitis

Brief summary

The purpose of this study is to determine whether the use of sterile or clean gloves during labor exams affects the rate of chorioamnionitis. Chorioamnionitis is an infection of the membranes around the baby.

Detailed description

The importance of this study is that intrapartum vaginal exams (while patients are laboring) are performed routinely in modern obstetrical practice, and there is no randomized trial available assessing the relationship between the type of glove used and the rate of chorioamnionitis.

Interventions

OTHERType of glove used for intrapartum vaginal exams

Patients will be randomized to either sterile or clean gloves during intrapartum vaginal exams.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Spontaneous or induced labor * Rupture of membranes \< 12 hours * Nulliparous or multiparous * Gestational age greater than or equal to 34 weeks * Age greater than or equal to 18

Exclusion criteria

* Contraindications to labor * Multiple gestations * Rupture of Membranes greater than 12 hours * Gestational age less than 34 weeks * Non-English speaking patients

Design outcomes

Primary

MeasureTime frameDescription
Clinical chorioamnionitisparticipants will be followed during their intrapartum hospital stay, an expected average of 48-72hrsClinical chorioamnionitis with at least two of the four criteria met-maternal fever of 38 degrees Celsius or greater, maternal tachycardia (pulse \>100), fetal tachycardia (fetal heart rate \>160), and/or fundal tenderness

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026